Aroa Biosurgery Sets Dates for Half-Year Results and Investor Events
ARX: $0.485 -1.02% · MC: $179M
Aroa Biosurgery will discuss its half-year results at a webinar and hold an in-person Sydney investor event later this month, covering its commercial outlook, clinical evidence and growth opportunities. The announcement follows the appointment of Mark Dunwoodie as CFO, effective later this month, as James Agnew prepares to depart.

Comments